文献速递神经重症功能神经外科

超越特发性颅内高压:基于机制的视神经减压术在脑脊液流动障碍中保护视力

Beyond idiopathic intracranial hypertension: optic nerve decompression for vision preservation in cerebrospinal fluid flow disorders. A mechanism-based approach.
PubMed 文献 · J Neurosurg · 2025-12-05

本研究回顾性分析26例脑脊液流动障碍伴视力损害患者的30只眼,基于腰椎灌注试验和眶部MRI选择内镜或开窗视神经鞘减压术;24个月随访显示视野平均偏差中位改善+1.89 dB,P100潜伏期缩短5毫秒,87.5%患眼视乳头水肿消退,所有脑脊液病理亚组均获视力改善。

要点

  • 腰椎灌注试验和眶部MRI可指导视神经减压术,不依赖特发性颅内高压诊断标准。
  • 视神经减压术可稳定或改善脑脊液相关视神经病变的视力,包括颅内压不高者。
  • 按脑脊液病理生理分三型有助于个体化手术决策,扩大手术适应人群。

核心结论

  • 基于脑脊液灌注试验和眶部MRI的视神经减压术可稳定或改善脑脊液相关视神经病变患者的视力,包括颅内压未升高者。
  • 基于机制的三型分类可实现超越综合征定义的个体化治疗,可能重新定义手术适应证。

研究设计与样本

  • 回顾性研究,纳入26例脑脊液流动异常伴进行性视力损害患者的30只眼。
  • 所有患者行标准化腰椎灌注试验量化脑脊液流出阻力、压力-容积指数和开放压力。
  • 眶部MRI评估视神经周围脑脊液聚集或视神经管狭窄,据此选择视神经鞘开窗术或内镜下视神经鞘减压术。
  • 基线及术后6、24个月评估视野平均偏差、视觉诱发电位和视网膜神经纤维层厚度。

主要发现

  • 视野平均偏差中位改善+1.89 dB(p < 0.05),24个月时P100潜伏期缩短5毫秒。
  • 87.5%受累眼视乳头水肿消退。
  • 视网膜神经纤维层厚度整体稳定或轻度增加,内镜组6和24个月均增厚+9 µm,开窗组6个月+1 µm、24个月-2 µm,差异无统计学意义。
  • 两种手术方式功能结局无显著差异。
  • 三个脑脊液病理亚组(颅内压升高的特发性颅内高压、颅内压不高的异常流体动力学、颅内压和流体动力学正常但MRI证实视神经周围脑脊液聚集)均见视力改善。

关键数值与推荐

  • 视野平均偏差中位改善+1.89 dB(p < 0.05)。
  • P100潜伏期缩短5毫秒。
  • 视乳头水肿消退率87.5%。
  • 内镜组视网膜神经纤维层厚度6和24个月均+9 µm,开窗组6个月+1 µm、24个月-2 µm。

临床怎么用

  • 对进行性视力损害且存在脑脊液流动异常证据者,可行腰椎灌注试验和眶部MRI评估。
  • 根据灌注试验和MRI结果选择视神经鞘开窗术或内镜下视神经鞘减压术。
  • 不应仅凭特发性颅内高压诊断标准决定手术资格,颅内压不高者也可能获益。

局限性

  • 回顾性研究,样本量较小(26例患者30只眼)。
  • 两种手术方式比较的差异无统计学意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate the long-term visual outcomes following optic nerve decompression in patients with CSF flow disturbances and to propose a mechanistic framework for surgical qualification based on infusion testing and orbital MRI, independent of idiopathic intracranial hypertension (IIH) diagnostic criteria. METHODS: This retrospective study analyzed 30 eyes in 26 patients with progressive visual impairment and evidence of CSF flow abnormalities. All patients underwent standardized lumbar infusion testing to quantify CSF outflow resistance, pressure-volume index, and opening pressure. Orbital MRI was used to assess perioptic CSF collections or optic canal narrowing. On the basis of these data, patients underwent either optic nerve sheath fenestration (ONSF) or endoscopic optic nerve sheath decompression (EONSD). Visual function was evaluated using mean deviation of the visual field, visual evoked potentials, and optical coherence tomography of the retinal nerve fiber layer (RNFL) thickness at baseline and 6 and 24 months. RESULTS: Mean deviation of the visual field improved by a median of +1.89 dB (p < 0.05), and P100 latency (i.e., the time between a visual stimulus and the visual cortex's response) decreased by -5 msec at 24 months. Papilledema resolved in 87.5% of affected eyes. RNFL thickness remained stable or modestly increased across the cohort, with a trend toward greater thickening following EONSD (+9 µm at both 6 and 24 months) compared with ONSF (minimal change at 6 months [+1 µm] and slight thinning at 24 months [-2 µm]), although the differences were not statistically significant. No significant differences in functional outcomes were observed between the procedures. Patients were stratified into 3 CSF pathophysiological subgroups: 1) IIH with elevated intracranial pressure (ICP), 2) abnormal hydrodynamics without raised ICP, and 3) normal ICP and hydrodynamics with MRI-confirmed perioptic CSF collection. Visual improvement occurred across all subgroups, including groups 2 and 3. CONCLUSIONS: The authors found that optic nerve decompression guided by CSF infusion testing and orbital MRI effectively stabilizes or improves visual function in patients with CSF-related optic neuropathy, including those without elevated ICP. A mechanism-based classification into three surgical phenotypes enables individualized treatment beyond syndromic definitions. This approach may redefine surgical eligibility and expand access to vision-preserving interventions in CSF-mediated optic nerve dysfunction.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Prokop K, Opęchowska A, Sawicki K, et al. Beyond idiopathic intracranial hypertension: optic nerve decompression for vision preservation in cerebrospinal fluid flow disorders. A mechanism-based approach. J Neurosurg. 2025. PMID: 41349016. doi:10.3171/2025.8.JNS251211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。